Literature DB >> 7667898

Approaches to the development of novel antihypertensive drugs: crucial role of the renal kallikrein-kinin system.

M Majima1, M Katori.   

Abstract

The renal kallikrein-kinin system has been shown to be important in the development of hypertension, but its precise role remains to be determined. The recent use of mutant rats that are deficient in plasma kininogens and hence incapable of generating kinin in the renal tubules has facilitated elucidation of the involvement of kinin in hypertension. In this article, Masataka Majima and Makoto Katori provide evidence that the renal kallikrein-kinin system plays a crucial role in the development of hypertension and discuss a novel rationale for developing effective new antihypertensive drugs.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7667898     DOI: 10.1016/s0165-6147(00)89033-1

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  5 in total

1.  Comparison of enalapril and valsartan in cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats on high-sodium diet.

Authors:  M Lassila; P Finckenberg; A K Pere; L Krogerus; J Ahonen; H Vapaatalo; M L Nurminen
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

2.  Early increases in renal kallikrein secretion on administration of potassium or ATP-sensitive potassium channel blockers in rats.

Authors:  T Fujita; I Hayashi; Y Kumagai; N Inamura; M Majima
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

3.  Role of bradykinin receptors in the renal effects of inhibition of angiotensin converting enzyme and endopeptidases 24.11 and 24.15 in conscious rabbits.

Authors:  F Tomoda; R A Lew; A I Smith; A C Madden; R G Evans
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

4.  Bradykinin inhibits development of myocardial infarction through B2 receptor signalling by increment of regional blood flow around the ischaemic lesions in rats.

Authors:  Hiroshi Ito; Izumi Hayashi; Tohru Izumi; Masataka Majima
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

Review 5.  A Novel Category of Anti-Hypertensive Drugs for Treating Salt-Sensitive Hypertension on the Basis of a New Development Concept.

Authors:  Makoto Katori; Masataka Majima
Journal:  Pharmaceuticals (Basel)       Date:  2010-01-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.